- Jul 25, 2012
- 12,967
- 1,970
- 25,680
Merckx index said:Well, I'm one of these old guys, and I embrace it.
Then I need you to talk to my collaborators!
The difference is that someone's career is at stake. When there is urgency--a major discovery, and scientists trying to be the first to publish--the review process, as I'm sure you know, is greatly expedited. It can be done. And when a decision about whether to strip someone of his job for two or more years is involved, the same if not greater urgency ought to be in effect. Remember, the rider is continuing to compete, and maybe getting results which might have to be nullified.
I can understand being slow in the initial phase, when they are trying to see if a profile is suspicious enough to warrant a further review (though the software is supposed to take most of these cases out of the scientists' hands). But when it gets to the point when they think they have a case, things ought to move much faster. There have been less than a dozen or so cases so far, so it's not like the pipeline is clogged.
Our paper was a first to publish finding (although the area it was in meant that at least one of the reviewers work directly disagreed with ours so no doubt that held it up a bit).
I completely agree that the impact of these things means that they should be dealt with much quicker. I just think that it's the most likely cause rather than a conspiracy, especially if there was disagreement between the experts at each stage.
It's certainly something they should be sorting out.
